GEN Strangle Strategy
GEN (Gen Digital Inc.), in the Technology sector, (Software - Infrastructure industry), listed on NASDAQ.
Gen Digital Inc. provides cyber safety solutions for consumers in the United States, Canada, Latin America, Europe, the Middle East, Africa, the Asia Pacific, and Japan. It offers Norton 360, an integrated platform provides extensive cyber safety coverage and a subscription service providing protection for PCs, Macs, and mobile devices against malware, viruses, adware, ransomware, and other online threats on various platforms; and Norton and LifeLock identity theft protection solution that offers monitoring, alerts, and restoration services to its customers. The company also provides Norton Secure VPN solution, which enhances security and online privacy by providing an encrypted data tunnel; Privacy Monitor Assistant, an on-demand, white glove service where agents help members delete personal information from data brokers online; Home Title Protect product that detects fraud and notifies members; and Avira Security, a consumer-focused portfolio of cybersecurity and privacy solutions. It offers Dark Web Monitoring product, which looks for personal information of its Norton 360 members on the Dark Web; and Social Media Monitoring solution that helps to keep customers' social media accounts safer by monitoring them for account takeovers, risky activity, and inappropriate content. The company also provides AntiTrack product, which helps to keep personal information and browsing activity private by blocking trackers and disguising digital fingerprints online; and Online Reputation Management solution that manages online search results, personal branding, and digital privacy. It markets and sells its products and related services through retailers, telecom service providers, hardware original equipment manufacturers, and employee benefit providers, as well as e-commerce platform.
GEN (Gen Digital Inc.) trades in the Technology sector, specifically Software - Infrastructure, with a market capitalization of approximately $14.11B, a trailing P/E of 14.41, a beta of 1.09 versus the broader market, a 52-week range of 17.78-32.22, average daily share volume of 7.2M, a public-listing history dating back to 1989, approximately 3K full-time employees. These structural characteristics shape how GEN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.09 places GEN roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline. GEN pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on GEN?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current GEN snapshot
As of May 15, 2026, spot at $23.52, ATM IV 35.30%, IV rank 34.48%, expected move 10.12%. The strangle on GEN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on GEN specifically: GEN IV at 35.30% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 10.12% (roughly $2.38 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated GEN expiries trade a higher absolute premium for lower per-day decay. Position sizing on GEN should anchor to the underlying notional of $23.52 per share and to the trader's directional view on GEN stock.
GEN strangle setup
The GEN strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With GEN near $23.52, the first option leg uses a $25.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed GEN chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 GEN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $25.00 | $0.40 |
| Buy 1 | Put | $22.00 | $0.58 |
GEN strangle risk and reward
- Net Premium / Debit
- -$97.50
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$97.50
- Breakeven(s)
- $21.03, $25.98
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
GEN strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on GEN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$2,101.50 |
| $5.21 | -77.9% | +$1,581.57 |
| $10.41 | -55.7% | +$1,061.64 |
| $15.61 | -33.6% | +$541.71 |
| $20.81 | -11.5% | +$21.78 |
| $26.01 | +10.6% | +$3.15 |
| $31.21 | +32.7% | +$523.08 |
| $36.41 | +54.8% | +$1,043.01 |
| $41.60 | +76.9% | +$1,562.94 |
| $46.80 | +99.0% | +$2,082.87 |
When traders use strangle on GEN
Strangles on GEN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the GEN chain.
GEN thesis for this strangle
The market-implied 1-standard-deviation range for GEN extends from approximately $21.14 on the downside to $25.90 on the upside. A GEN long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current GEN IV rank near 34.48% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on GEN should anchor more to the directional view and the expected-move geometry. As a Technology name, GEN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to GEN-specific events.
GEN strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. GEN positions also carry Technology sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move GEN alongside the broader basket even when GEN-specific fundamentals are unchanged. Always rebuild the position from current GEN chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on GEN?
- A strangle on GEN is the strangle strategy applied to GEN (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With GEN stock trading near $23.52, the strikes shown on this page are snapped to the nearest listed GEN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are GEN strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the GEN strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 35.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$97.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a GEN strangle?
- The breakeven for the GEN strangle priced on this page is roughly $21.03 and $25.98 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current GEN market-implied 1-standard-deviation expected move is approximately 10.12%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on GEN?
- Strangles on GEN are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the GEN chain.
- How does current GEN implied volatility affect this strangle?
- GEN ATM IV is at 35.30% with IV rank near 34.48%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.